Pelletier; Jeffrey Claude

Patent Applications and Registrations

Patent applications and USPTO patent grants for Pelletier; Jeffrey Claude.The latest application filed is for "map kinase modulators and uses thereof".

Company Profile

5.8.24

Pelletier; Jeffrey Claude - Lafayette Hill PA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Prodrugs of riluzole and their method of use Grant 11,440,893 - Smith , et al. September 13, 2	2022-09-13
Map Kinase Modulators And Uses Thereof App 20220009905 - ARANCIO; Ottavio ; et al.	2022-01-13
Prodrugs Of Cgrp Antagonists App 20210395223 - Conway; Charles M. ; et al.	2021-12-23
MAP kinase modulators and uses thereof Grant 11,149,020 - Arancio , et al. October 19, 2	2021-10-19
Riluzole Prodrugs And Their Use App 20210236471 - Wrobel; Jay Edward ; et al.	2021-08-05
Prodrugs Of Riluzole And Their Method Of Use App 20210236470 - Wrobel; Jay Edward ; et al.	2021-08-05
Riluzole Prodrugs And Their Use App 20210228549 - Wrobel; Jay Edward ; et al.	2021-07-29
Prodrugs Of Riluzole And Their Method Of Use App 20210078962 - Smith; Garry Robert ; et al.	2021-03-18
Prodrugs of riluzole and their method of use Grant 10,844,026 - Smith , et al. November 24, 2	2020-11-24
Map Kinase Modulators And Uses Thereof App 20190389840 - ARANCIO; Ottavio ; et al.	2019-12-26
MAP kinase modulators and uses thereof Grant 10,428,047 - Arancio , et al. October 1, 2	2019-10-01
Riluzole Prodrugs And Their Use App 20180036290 - Wrobel; Jay Edward ; et al.	2018-02-08
Prodrugs Riluzole And Their Method Of Use App 20180037557 - Wrobel; Jay Edward ; et al.	2018-02-08
Map Kinase Modulators And Uses Thereof App 20170369472 - ARANCIO; Ottavio ; et al.	2017-12-28
Map kinase modulators and uses thereof Grant 9,783,525 - Arancio , et al. October 10, 2	2017-10-10
Map Kinase Modulators And Uses Thereof App 20160130253 - ARANCIO; Ottavio ; et al.	2016-05-12
Prodrugs Of Riluzole And Their Method Of Use App 20150045401 - Smith; Garry Robert ; et al.	2015-02-12
Gonadotropin releasing hormone receptor antagonists Grant 7,696,210 - Garrick , et al. April 13, 2	2010-04-13
Imidazopyridine Analogs And Their Use As Agonists Of The Wnt-beta-catenin Cellular Messaging System App 20090069319 - Lundquist, IV; Joseph Theodore ; et al.	2009-03-12
Naphthylpyrimidine, Naphthylpyrazine And Naphthylpyridazine Analogs And Their Use As Agonists Of The Wnt-beta-catenin Cellular Messaging System App 20090054392 - Pelletier; Jeffrey Claude ; et al.	2009-02-26
Pyrimidine Sulfonamide Analogs And Their Use As Agonists Of The Wnt-beta-catenin Cellular Messaging System App 20090048282 - Hauze; Diane Barbara ; et al.	2009-02-19
Heteroaryl/aryl Pyrimidine Analogs And Their Use As Agonists Of The Wnt-beta-catenin Cellular Messaging System App 20080287452 - BURSAVICH; Matthew Gregory ; et al.	2008-11-20
Piperazinylimidazopyridine and piperazinyltriazolopyridine antagonists of gonadotropin releasing hormone receptor App 20060270848 - Lundquist; Joseph Theodore IV ; et al.	2006-11-30
Benzooxazole and benzothiazole antagonists of gonadotropin releasing hormone receptor App 20060264631 - Green; Daniel Michael ; et al.	2006-11-23
4-Substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor App 20060189618 - Pelletier; Jeffrey Claude	2006-08-24
Imidazo[4,5-b]pyridine antagonists of gonadotropin releasing hormone receptor App 20060189617 - Pelletier; Jeffrey Claude ; et al.	2006-08-24
7-Substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor App 20060189616 - Pelletier; Jeffrey Claude ; et al.	2006-08-24
Gonadotropin releasing hormone receptor antagonists App 20060111355 - Garrick; Lloyd Michael ; et al.	2006-05-25
Gonadotropin releasing hormone receptor antagonists App 20060019965 - Garrick; Lloyd Michael ; et al.	2006-01-26
Aryl substituted 1,4-diazepanes and method of use thereof Grant 6,667,303 - Gu , et al. December 23, 2	2003-12-23
Substituted 2-(S)-hydroxy-3-(piperidin-4-yl-methylamino)-propyl ethers and substituted 2-aryl-2-(R)-hydroxy-1-(piperidin-4-yl-methyl)-ethylamine .beta.-3 adrenergic receptor agonists Grant 6,506,901 - Steffan , et al. January 14, 2	2003-01-14
Novel Bicyclic and tricyclic pyrrolidine derivatives as GnRH antagonists App 20020065309 - Peng, Ge ; et al.	2002-05-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.